Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2021

Open Access 01-12-2021 | CABG | Research article

Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG

Authors: Aida Fallahzadeh, Ali Sheikhy, Ali Ajam, Saeed Sadeghian, Mina Pashang, Mahmoud Shirzad, Jamshid Bagheri, Soheil Mansourian, Shahram Momtahen, Kaveh Hosseini

Published in: Journal of Cardiothoracic Surgery | Issue 1/2021

Login to get access

Abstract

Background

Pre-operative ejection fraction (EF) and comorbidities affect post-op outcomes. We aimed to compare the mortality and adverse events of patients with different baseline EF and also to evaluate the distribution of comorbidities in each EF group.

Methods

A total of 20,937 patients who underwent isolated coronary artery bypass graft (CABG) surgery from January 2006 to December 2016 was included. Patients were divided into three groups based on their pre-operative left ventricular EF as follows; (1) Normal: EF ≥ 50%; (2) Mild to moderately reduced: 50% < EF ≤ 35%; and (3) Severely reduced: EF < 35%. The backward elimination method was considered for multivariate Cox-regression analysis to locate predictors of mortality and non-fatal cerebro-cardiovascular events (CCVEs). The median follow-up time was 5.61 [3.12–8.0] years.

Results

The mean age in the total population was 60.94 ± 9.51 years and 73.6% of the total population was male. Diabetes mellitus was the common risk factor of mortality and CCVE in all EF groups. Impaired renal function (GFR < 60 ml/min) was associated with a higher risk of mortality after CABG regardless of EF level. The median 5-year mortality rate in patients with normal EF, mild-moderately reduced EF and severely reduced EF were 9.5%, 12.8%, and 22.7% respectively (P < 0.001). Although the trend of CCVEs was higher in severe left ventricle (LV) dysfunction, it was not statistically significant (p = 0.071).

Conclusion

Patients with severely reduced EF are at higher risk of mortality after CABG compared to those with higher EF levels; however, the rate of CCVEs may not be necessarily higher after adjustment for multiple pre-operative comorbidities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brown JC, Gerhardt TE, Kwon E. risk factors for coronary artery disease. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC.; 2021. Brown JC, Gerhardt TE, Kwon E. risk factors for coronary artery disease. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC.; 2021.
2.
go back to reference Spadaccio C, Benedetto U. Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? A review of the evidences on coronary artery disease. Ann Cardiothoracic Surg. 2018;7(4):506–15. Spadaccio C, Benedetto U. Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? A review of the evidences on coronary artery disease. Ann Cardiothoracic Surg. 2018;7(4):506–15.
3.
go back to reference Soliman Hamad MA, van Straten AH, van Zundert AA, ter Woorst JF, Martens EJ, Penn OC. Preoperative prediction of early mortality in patients with low ejection fraction undergoing coronary artery bypass grafting. J Card Surg. 2011;26(1):9–15.CrossRef Soliman Hamad MA, van Straten AH, van Zundert AA, ter Woorst JF, Martens EJ, Penn OC. Preoperative prediction of early mortality in patients with low ejection fraction undergoing coronary artery bypass grafting. J Card Surg. 2011;26(1):9–15.CrossRef
4.
go back to reference Kamal YA A-ES, Ghoneim A, El-Minshawy A. Traditional predictors of in-hospital mortality after coronary artery bypass grafting: current status. 2017. Kamal YA A-ES, Ghoneim A, El-Minshawy A. Traditional predictors of in-hospital mortality after coronary artery bypass grafting: current status. 2017.
5.
go back to reference Heijmans JH, Maessen JG, Roekaerts PM. Risk stratification for adverse outcome in cardiac surgery. Eur J Anaesthesiol. 2003;20(7):515–27.CrossRef Heijmans JH, Maessen JG, Roekaerts PM. Risk stratification for adverse outcome in cardiac surgery. Eur J Anaesthesiol. 2003;20(7):515–27.CrossRef
6.
go back to reference Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68(4):785–95.CrossRef Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68(4):785–95.CrossRef
7.
go back to reference Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med. 1985;312(26):1665–71. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med. 1985;312(26):1665–71.
8.
go back to reference Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511–20.CrossRef Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511–20.CrossRef
9.
go back to reference Zubiate P, Kay JH, Mendez AM. Myocardial revascularization for the patient with drastic impairment of function of the left ventricle. J Thorac Cardiovasc Surg. 1977;73(1):84–6.CrossRef Zubiate P, Kay JH, Mendez AM. Myocardial revascularization for the patient with drastic impairment of function of the left ventricle. J Thorac Cardiovasc Surg. 1977;73(1):84–6.CrossRef
10.
go back to reference Christakis GT, Weisel RD, Fremes SE, Ivanov J, David TE, Goldman BS, et al. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg. 1992;103(6):1083–92.CrossRef Christakis GT, Weisel RD, Fremes SE, Ivanov J, David TE, Goldman BS, et al. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg. 1992;103(6):1083–92.CrossRef
11.
go back to reference Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112(9_supplement):I-344-I-50. Topkara VK, Cheema FH, Kesavaramanujam S, Mercando ML, Cheema AF, Namerow PB, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112(9_supplement):I-344-I-50.
12.
go back to reference Kamal YA, Al-Elwany SEM, Ghoneim AMF, El-Minshawy AMK. Predictors of adverse effects after coronary artery bypass grafting in patients with reduced left ventricular ejection fraction. J Egypt Soc Cardio-Thoracic Surg. 2017;25(1):20–7.CrossRef Kamal YA, Al-Elwany SEM, Ghoneim AMF, El-Minshawy AMK. Predictors of adverse effects after coronary artery bypass grafting in patients with reduced left ventricular ejection fraction. J Egypt Soc Cardio-Thoracic Surg. 2017;25(1):20–7.CrossRef
13.
go back to reference Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol. 1999;33(5):1424–6.CrossRef Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol. 1999;33(5):1424–6.CrossRef
14.
go back to reference Bytyçi I, Shenouda R, Wester P, Henein MY. Carotid atherosclerosis in predicting coronary artery disease. Arterioscler Thromb Vasc Biol. 2021;41(4):e224–37.CrossRef Bytyçi I, Shenouda R, Wester P, Henein MY. Carotid atherosclerosis in predicting coronary artery disease. Arterioscler Thromb Vasc Biol. 2021;41(4):e224–37.CrossRef
15.
go back to reference Poorhosseini H, Abbasi SH. The Tehran Heart Center. Eur Heart J. 2018;39(29):2695–6.CrossRef Poorhosseini H, Abbasi SH. The Tehran Heart Center. Eur Heart J. 2018;39(29):2695–6.CrossRef
16.
go back to reference R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2020. R Core Team (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2020.
17.
go back to reference (2021). TT. A Package for Survival Analysis in R_. R package version 3.2–10. 2021. (2021). TT. A Package for Survival Analysis in R_. R package version 3.2–10. 2021.
18.
go back to reference Alboukadel Kassambara MKaPB. survminer: Drawing Survival Curves using 'ggplot2'. R package version 0.4.9. 2021. Alboukadel Kassambara MKaPB. survminer: Drawing Survival Curves using 'ggplot2'. R package version 0.4.9. 2021.
19.
go back to reference Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2016.CrossRef Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2016.CrossRef
20.
go back to reference Maltais S, Ladouceur M, Cartier R. The influence of a low ejection fraction on long-term survival in systematic off-pump coronary artery bypass surgery☆. Eur J Cardiothorac Surg. 2011;39(5):e122–7.CrossRef Maltais S, Ladouceur M, Cartier R. The influence of a low ejection fraction on long-term survival in systematic off-pump coronary artery bypass surgery☆. Eur J Cardiothorac Surg. 2011;39(5):e122–7.CrossRef
21.
go back to reference El-Shafey W, Elnagar T, Kamal A, Kamal A. Early results of coronary artery bypass graft (CABG) in patients with low ejection fraction. World J Cardiovasc Dis. 2020;10:319–28.CrossRef El-Shafey W, Elnagar T, Kamal A, Kamal A. Early results of coronary artery bypass graft (CABG) in patients with low ejection fraction. World J Cardiovasc Dis. 2020;10:319–28.CrossRef
22.
go back to reference Kurlansky P, Herbert M, Prince S, Mack M. Coronary bypass versus percutaneous intervention: sex matters. The impact of gender on long-term outcomes of coronary revascularization. Eur J Cardio-Thoracic Surg. 2017;51(3):554–61. Kurlansky P, Herbert M, Prince S, Mack M. Coronary bypass versus percutaneous intervention: sex matters. The impact of gender on long-term outcomes of coronary revascularization. Eur J Cardio-Thoracic Surg. 2017;51(3):554–61.
23.
go back to reference Huckaby LV, Seese LM, Sultan I, Gleason TG, Wang Y, Thoma F, et al. The impact of sex on outcomes after revascularization for multivessel coronary disease. Ann Thorac Surg. 2020;110(4):1243–50.CrossRef Huckaby LV, Seese LM, Sultan I, Gleason TG, Wang Y, Thoma F, et al. The impact of sex on outcomes after revascularization for multivessel coronary disease. Ann Thorac Surg. 2020;110(4):1243–50.CrossRef
24.
go back to reference Alam M, Bandeali SJ, Kayani WT, Ahmad W, Shahzad SA, Jneid H, et al. Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol. 2013;112(3):309–17.CrossRef Alam M, Bandeali SJ, Kayani WT, Ahmad W, Shahzad SA, Jneid H, et al. Comparison by meta-analysis of mortality after isolated coronary artery bypass grafting in women versus men. Am J Cardiol. 2013;112(3):309–17.CrossRef
25.
go back to reference Erguneş K, Yilik L, Yetkin U, Lafcı B, Bayrak S, Ozpak B, et al. Early and mid-term outcomes in female patients undergoing isolated conventional coronary surgery. J Cardiovasc Thorac Res. 2014;6(2):105–10.PubMedPubMedCentral Erguneş K, Yilik L, Yetkin U, Lafcı B, Bayrak S, Ozpak B, et al. Early and mid-term outcomes in female patients undergoing isolated conventional coronary surgery. J Cardiovasc Thorac Res. 2014;6(2):105–10.PubMedPubMedCentral
26.
go back to reference De Marco T, Chatterjee K, Rouleau JL, Parmley WW. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J. 1988;115(4):809–15.CrossRef De Marco T, Chatterjee K, Rouleau JL, Parmley WW. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J. 1988;115(4):809–15.CrossRef
27.
go back to reference Shapira OM, Hunter CT, Anter E, Bao Y, DeAndrade K, Lazar HL, et al. Coronary artery bypass grafting in patients with severe left ventricular dysfunction–early and mid-term outcomes. J Card Surg. 2006;21(3):225–32.CrossRef Shapira OM, Hunter CT, Anter E, Bao Y, DeAndrade K, Lazar HL, et al. Coronary artery bypass grafting in patients with severe left ventricular dysfunction–early and mid-term outcomes. J Card Surg. 2006;21(3):225–32.CrossRef
28.
go back to reference Vickneson K, Chan SP, Li Y, Bin Abdul Aziz MN, Luo HD, Kang GS, et al. Coronary artery bypass grafting in patients with low ejection fraction: what are the risk factors? J Cardiovasc Surg. 2019;60(3):396–405. Vickneson K, Chan SP, Li Y, Bin Abdul Aziz MN, Luo HD, Kang GS, et al. Coronary artery bypass grafting in patients with low ejection fraction: what are the risk factors? J Cardiovasc Surg. 2019;60(3):396–405.
29.
go back to reference Khaled S, Kasem E, Fadel A, alzahrani Y, Banjar K, Al-Zahrani Wa, et al. Left ventricular function outcome after coronary artery bypass grafting, King Abdullah Medical City (KAMC)- single-center experience. Egypt Heart J. 2019;71(1):2. Khaled S, Kasem E, Fadel A, alzahrani Y, Banjar K, Al-Zahrani Wa, et al. Left ventricular function outcome after coronary artery bypass grafting, King Abdullah Medical City (KAMC)- single-center experience. Egypt Heart J. 2019;71(1):2.
30.
go back to reference Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, et al. Long-term outcome of PCI versus CABG in insulin and non–insulin-treated diabetic patients: results from the FREEDOM Trial. J Am Coll Cardiol. 2014;64(12):1189–97.CrossRef Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C, et al. Long-term outcome of PCI versus CABG in insulin and non–insulin-treated diabetic patients: results from the FREEDOM Trial. J Am Coll Cardiol. 2014;64(12):1189–97.CrossRef
31.
go back to reference Gatti G, Maschietto L, Dell’Angela L, Benussi B, Forti G, Dreas L, et al. Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction. Heart Vessels. 2016;31(7):1045–55.CrossRef Gatti G, Maschietto L, Dell’Angela L, Benussi B, Forti G, Dreas L, et al. Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction. Heart Vessels. 2016;31(7):1045–55.CrossRef
32.
go back to reference Abdi-Ali A, Shaheen A, Southern D, Zhang M, Knudtson M, White J, et al. Relation between family history of premature coronary artery disease and the risk of death in patients with coronary artery disease. Am J Cardiol. 2015;117. Abdi-Ali A, Shaheen A, Southern D, Zhang M, Knudtson M, White J, et al. Relation between family history of premature coronary artery disease and the risk of death in patients with coronary artery disease. Am J Cardiol. 2015;117.
33.
go back to reference Chow CK, Islam S, Bautista L, Rumboldt Z, Yusufali A, Xie C, et al. Parental history and myocardial infarction risk across the world: the INTERHEART Study. J Am Coll Cardiol. 2011;57(5):619–27.CrossRef Chow CK, Islam S, Bautista L, Rumboldt Z, Yusufali A, Xie C, et al. Parental history and myocardial infarction risk across the world: the INTERHEART Study. J Am Coll Cardiol. 2011;57(5):619–27.CrossRef
34.
go back to reference Williamson C, Jeemon P, Hastie CE, McCallum L, Muir S, Dawson J, et al. Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. Eur Heart J. 2014;35(9):563–70.CrossRef Williamson C, Jeemon P, Hastie CE, McCallum L, Muir S, Dawson J, et al. Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients. Eur Heart J. 2014;35(9):563–70.CrossRef
35.
go back to reference Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation. 2008;118(18):1785–92.CrossRef Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation. 2008;118(18):1785–92.CrossRef
36.
go back to reference Philip F, Blackstone E, Kapadia SR. Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery. Cardiovasc Diagn Ther. 2015;5(1):8–16.PubMedPubMedCentral Philip F, Blackstone E, Kapadia SR. Impact of statins and beta-blocker therapy on mortality after coronary artery bypass graft surgery. Cardiovasc Diagn Ther. 2015;5(1):8–16.PubMedPubMedCentral
37.
go back to reference Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, et al. Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). Am J Cardiol. 2012;110(9):1256–61.CrossRef Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, et al. Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). Am J Cardiol. 2012;110(9):1256–61.CrossRef
38.
go back to reference Agarwal MA, Garg L, Lavie CJ, Reed GL, Khouzam RN. Impact of family history of coronary Artery disease on in-hospital clinical outcomes in ST-segment myocardial infarction. Ann Transl Med. 2018;6(1):3.CrossRef Agarwal MA, Garg L, Lavie CJ, Reed GL, Khouzam RN. Impact of family history of coronary Artery disease on in-hospital clinical outcomes in ST-segment myocardial infarction. Ann Transl Med. 2018;6(1):3.CrossRef
Metadata
Title
Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG
Authors
Aida Fallahzadeh
Ali Sheikhy
Ali Ajam
Saeed Sadeghian
Mina Pashang
Mahmoud Shirzad
Jamshid Bagheri
Soheil Mansourian
Shahram Momtahen
Kaveh Hosseini
Publication date
01-12-2021
Publisher
BioMed Central
Keywords
CABG
Diabetes
CABG
Published in
Journal of Cardiothoracic Surgery / Issue 1/2021
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-021-01732-3

Other articles of this Issue 1/2021

Journal of Cardiothoracic Surgery 1/2021 Go to the issue